FDA Inspection 874505 — Leo Pharma A/S

Leo Pharma A/S — FEI 3002807496

The FDA completed an inspection of Leo Pharma A/S on March 21, 2014 in Ballerup. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 21, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ballerup (Denmark)